Reactive oxygen species in tumor progression

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1881-1896

  Storz, Peter ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adhesion; Cancer; Migration; Oxygen Radicals; Review; ROS; Signal Transduction; Tumor

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; TUMOR NECROSIS FACTOR ALPHA;

CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DETOXIFICATION; GENE TARGETING; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PHENOTYPE; REVIEW; TUMOR GROWTH;

EID: 17244367828     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1667     Document Type: Review

References (201)

1. Cerutti, P. A.: Prooxidant states and tumor promotion. Science 227, 375-381 (1985)
2. Trush, M. A. & T. W. Kensler: An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med 10, 201-209 (1991)
3. Slaga, T. J., A. J. Klein-Szanto, L. L. Triplett, L. P. Yotti & K. E. Trosko: Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213, 1023-1025 (1981)
4. Gopalakrishna, R. & S. Jaken: Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28, 1349-1361 (2000)
5. Wiseman, H. & B. Halliwell: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 (Pt 1), 17-29 (1996)
6. Jackson, A. L. & L. A. Loeb: The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477, 7-21 (2001)
7. Finkel, T.: Oxidant signals and oxidative stress. Curr Opin Cell Biol 15, 247-254 (2003)
8. Baeuerle, P. A., R. A. Rupee & H. L. Pahl: Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol Biol (Paris) 44, 29-35 (1996)
9. Imlay, J. A., S. M. Chin & S. Linn: Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240, 640-642 (1988)
10. Jackson, J. H.: Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ Health Perspect 102 Suppl 10, 155-157 (1994)
11. Chance, B., H. Sies & A. Boveris: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59, 527-605 (1979)
12. Mello Filho, A. C. & R. Meneghini: In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim Biophys Acta 781, 56-63 (1984)
13. Cui, S., J. S. Reichner, R. B. Mateo & J. E. Albina: Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 54, 2462-2467 (1994)
14. Szatrowski, T. P. & C. F. Nathan: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51, 794-798 (1991)
15. Bae, Y. S., S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock & S. G. Rhee: Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272, 217-221 (1997)
16. Portakal, O., O. Ozkaya, M. Erden Inal, B. Bozan, M. Kosan & I. Sayek: Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33, 279-284 (2000)
17. Aggarwal, B. B., A. Bhardwaj, R. S. Aggarwal, N. P. Seeram, S. Shishodia & Y. Takada: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24, 2783-2840 (2004)
18. Toyokuni, S., K. Okamoto, J. Yodoi & H. Hiai: Persistent oxidative stress in cancer. FEBS Lett 358, 1-3 (1995)
19. Arnold, R. S., J. Shi, E. Murad, A. M. Whalen, C. Q. Sun, R. Polavarapu, S. Parthasarathy, J. A. Petros & J. D. Lambeth: Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci U S A 98, 5550-5555 (2001)
20. Burdon, R. H., V. Gill & D. Alliangana: Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts. Free Radic Res 24, 81-93 (1996)
21. Burdon, R. H.: Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18, 775-794 (1995)
22. Burdon, R. H., V. Gill & C. Rice-Evans: Oxidative stress and tumour cell proliferation. Free Radic Res Commun 11, 65-76 (1990)
23. Behrend, L., G. Henderson & R. M. Zwacka: Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31, 1441-1444 (2003)
24. Wang, X., J. L. Martindale, Y. Liu & N. J. Holbrook: The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333 (Pt 2), 291-300 (1998)
25. Irani, K., Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel & P. J. Goldschmidt-Clermont: Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652 (1997)
26. Dang, C. V. & G. L. Semenza: Oncogenic alterations of metabolism. Trends Biochem Sci 24, 68-72 (1999)
27. Harris, A. L.: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38-47 (2002)
28. Hockel, M., K. Schlenger, S. Hockel & P. Vaupel: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59, 4525-4528 (1999)
29. Hockel, M. & P. Vaupel: Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266-276 (2001)
30. Prabhakar, N. R.: Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90, 1986-1994 (2001)
31. Maulik, N. & D. K. Das: Redox signaling in vascular angiogenesis. Free Radic Biol Med 33, 1047-1060 (2002)
32. Spitz, D. R., J. E. Sim, L. A. Ridnour, S. S. Galoforo & Y. J. Lee: Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci 899, 349-362 (2000)
33. Brown, N. S. & R. Bicknell: Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3, 323-327 (2001)
34. Milligan, S. A., M. W. Owens & M. B. Grisham: Augmentation of cytokine-induced nitric oxide synthesis by hydrogen peroxide. Am J Physiol 271, L114-120 (1996)
35. Simon, H. U., A. Haj-Yehia & F. Levi-Schaffer: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418 (2000)
36. Chung, Y. M., Y. S. Bae & S. Y. Lee: Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34, 434-442 (2003)
37. Gottlieb, E., M. G. Vander Heiden & C. B. Thompson: Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20, 5680-5689 (2000)
38. Li, P. F., R. Dietz & R. von Harsdorf: p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. Embo J 18, 6027-6036 (1999)
39. Pierce, G. B., R. E. Parchment & A. L. Lewellyn: Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 46, 181-186 (1991)
40. Shami, P. J., D. L. Sauls & J. B. Weinberg: Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide. Leukemia 12, 1461-1466 (1998)
41. Arrigo, A. P.: Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 379, 19-26 (1998)
42. Messmer, U. K., U. K. Reed & B. Brune: Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 271, 20192-20197 (1996)
43. Chen, Q. M., J. C. Bartholomew, J. Campisi, M. Acosta, J. D. Reagan & B. N. Ames: Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 332 (Pt 1), 43-50 (1998)
44. Lin, A. W., M. Barradas, J. C. Stone, L. van Aelst, M. Serrano & S. W. Lowe: Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12, 3008-3019 (1998)
45. Shackelford, R. E., W. K. Kaufmann & R. S. Paules: Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28, 1387-1404 (2000)
46. Kundu, N., S. Zhang & A. M. Fulton: Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis 13, 16-22 (1995)
47. Gregg, D., D. D. de Carvalho & H. Kovacic: Integrins and coagulation: a role for ROS/redox signaling? Antioxid Redox Signal 6, 757-764 (2004)
48. van Wetering, S., J. D. van Buul, S. Quik, F. P. Mul, E. C. Anthony, J. P. ten Klooster, J. G. Collard & P. L. Hordijk: Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 115, 1837-1846 (2002)
49. Moldovan, L., K. Irani, N. I. Moldovan, T. Finkel & P. J. Goldschmidt-Clermont: The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. Antioxid Redox Signal 1, 29-43 (1999)
50. Huot, J., F. Houle, F. Marceau & J. Landry: Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80, 383-392 (1997)
51. Rust, W., K. Kingsley, T. Petnicki, S. Padmanabhan, S. W. Carper & G. E. Plopper: Heat shock protein 27 plays two distinct roles in controlling human breast cancer cell migration on laminin-5. Mol Cell Biol Res Commun 1, 196-202 (1999)
52. Ben Mahdi, M. H., V. Andrieu & C. Pasquier: Focal adhesion kinase regulation by oxidative stress in different cell types. IUBMB Life 50, 291-299 (2000)
53. Roebuck, K. A.: Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int J Mol Med 4, 223-230 (1999)
54. Nelson, A. R., B. Fingleton, M. L. Rothenberg & L. M. Matrisian: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18, 1135-1149 (2000)
55. Duffy, M. J., T. M. Maguire, A. Hill, E. McDermott & N. O'Higgins: Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2, 252-257 (2000)
56. Rajagopalan, S., X. P. Meng, S. Ramasamy, D. G. Harrison & Z. S. Galis: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98, 2572-2579 (1996)
57. Nelson, K. K. & J. A. Melendez: Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37, 768-784 (2004)
58. Brenneisen, P., H. Sies & K. Scharffetter-Kochanek: Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann N Y Acad Sci 973, 31-43 (2002)
59. Wenk, J., P. Brenneisen, M. Wlaschek, A. Poswig, K. Briviba, T. D. Oberley & K. Scharffetter-Kochanek: Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274, 25869-25876 (1999)
60. Kheradmand, F., E. Werner, P. Tremble, M. Symons & Z. Werb: Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 280, 898-902 (1998)
61. Fu, X., S. Y. Kassim, W. C. Parks & J. W. Heinecke: Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metal loproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276, 41279-41287 (2001)
62. Lander, H. M., D. P. Hajjar, B. L. Hempstead, U. A. Mirza, B. T. Chait, S. Campbell & L. A. Quilliam: A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21 (ras) interaction. J Biol Chem 272, 4323-4326 (1997)
63. Thomas, P., R. Khokha, F. A. Shepherd, R. Feld & M. S. Tsao Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J Pathol 190, 150-156 (2000)
64. Westermarck, J. & V. M. Kahari: Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13, 781-792 (1999)
65. Church, S. L., J. W. Grant, L. A. Ridnour, L. W. Oberley, P. E. Swanson, P. S. Meltzer & J. M. Trent: Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A 90, 3113-3117 (1993)
66. Stone, J. R. & T. Collins: The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 9, 231-238 (2002)
67. Rhee, S. G., Y. S. Bae, S. R. Lee & J. Kwon: Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000, PE1 (2000)
68. Reed, S. G., C. F. Nathan, D. L. Pihl, P. Rodricks, K. Shanebeck, P. J. Conlon & K. H. Grabstein: Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J Exp Med 166, 1734-1746 (1987)
69. De Deken, X., D. Wang, M. C. Many, S. Costagliola, F. Libert, G. Vassart, J. E. Dumont & F. Miot: Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275, 23227-23233 (2000)
70. Nemoto, S. & T. Finkel: Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452 (2002)
71. Jackson, J. G., T. Yoneda, G. M. Clark & D. Yee: Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res 6, 1135-1139 (2000)
72. Boveris, A. & B. Chance: The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134, 707-716 (1973)
73. Dansen, T. B. & K. W. Wirtz: The peroxisome in oxidative stress. IUBMB Life 51, 223-230 (2001)
74. Singh, I.: Mammalian peroxisomes: metabolism of oxygen and reactive oxygen species. Ann N Y Acad Sci 804, 612-627 (1996)
75. del Rio, L. A., L. M. Sandalio, J. M. Palma, P. Bueno & F. J. Corpas: Metabolism of oxygen radicals in peroxisomes and cellular implications. Free Radic Biol Med 13, 557-580 (1992)
76. Kissner, R., T. Nauser, P. Bugnon, P. G. Lye & W. H. Koppenol: Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem Res Toxicol 10, 1285-1292 (1997)
77. Cadenas, E. & K. J. Davies: Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29, 222-230 (2000)
78. Jones, C. M., A. Lawrence, P. Wardman & M. J. Burkitt: Kinetics of superoxide scavenging by glutathione: an evaluation of its role in the removal of mitochondrial superoxide. Biochem Soc Trans 31, 1337-1339 (2003)
79. Wood, Z. A., E. Schroder, J. Robin Harris & L. B. Poole: Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28, 32-40 (2003)
80. Benhar, M., D. Engelberg & A. Levitzki: ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3, 420-425 (2002)
81. Tobiume, K., A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O. Minowa, K. Miyazono, T. Noda & H. Ichijo: ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2, 222-228 (2001)
82. Nauser, T. & C. Schoneich: Thiyl radicals abstract hydrogen atoms from the (alpha)C-H bonds in model peptides: absolute rate constants and effect of amino acid structure. J Am Chem Soc 125, 2042-2043 (2003)
83. Pogocki, D. & C. Schoneich: Thiyl radicals abstract hydrogen atoms from carbohydrates: reactivity and selectivity. Free Radic Biol Med 31, 98-107 (2001)
84. Neumann, C. A., D. S. Krause, C. V. Carman, S. Das, D. P. Dubey, J. L. Abraham, R. T. Bronson, Y. Fujiwara, S. H. Orkin & R. A. Van Etten: Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424, 561-565 (2003)
85. Kropotov, A. V., P. S. Grudinkin, N. M. Pleskach, B. A. Gavrilov, N. V. Tomilin & B. Zhivotovsky: Downregulation of peroxiredoxin V stimulates formation of etoposide-induced double-strand DNA breaks. FEBS Lett 572, 75-79 (2004)
86. Kim, H. J., H. Z. Chae, Y. J. Kim, Y. H. Kim, T. S. Hwangs, E. M. Park & Y. M. Park: Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol Toxicol 19, 285-298 (2003)
87. Jiang, D., W. Ying, Y. Lu, J. Wan, Y. Zhai, W. Liu, Y. Zhu, Z. Qiu, X. Qian & F. He: Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3, 724-737 (2003)
88. Karihtala, P., A. Mantyniemi, S. W. Kang, V. L. Kinnula & Y. Soini: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9, 3418-3424 (2003)
89. Lee, S. C., Y. P. Na & J. B. Lee: Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells. J Am Acad Dermatol 49, 487-491 (2003)
90. Choi, J. H., T. N. Kim, S. Kim, S. H. Baek, J. H. Kim, S. R. Lee & J. R. Kim: Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22, 3331-3335 (2002)
91. Nonn, L., M. Berggren & G. Powis: Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 1, 682-689 (2003)
92. Sundaresan, M., Z. X. Yu, V. J. Ferrans, D. J. Sulciner, J. S. Gutkind, K. Irani, P. J. Goldschmidt-Clermont & T. Finkel: Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318 (Pt 2), 379-382 (1996)
93. Sundaresan, M., Z. X. Yu, V. J. Ferrans, K. Irani & T. Finkel: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299 (1995)
94. Lo, Y. Y. & T. F. Cruz: Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270, 11727-11730 (1995)
95. Tiku, M. L., J. B. Liesch & F. M. Robertson: Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 145, 690-696 (1990)
96. Meier, B., H. H. Radeke, S. Selle, M. Younes, H. Sies, K. Resch & G. G. Habermehl: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 263, 539-545 (1989)
97. Cantley, L. C. & B. G. Neel: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96, 4240-4245 (1999)
98. Rameh, L. E. & L. C. Cantley: The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274, 8347-8350 (1999)
99. Suh, Y. A., R. S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A. B. Chung, K. K. Griendling & J. D. Lambeth: Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82 (1999)
100. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko & M. P. Boldin: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17, 331-367 (1999)
101. Ashkenazi, A. & V. M. Dixit: Death receptors: signaling and modulation. Science 281, 1305-1308 (1998)
102. Talley, A. K., S. Dewhurst, S. W. Perry, S. C. Dollard, S. Gummuluru, S. M. Fine, D. New, L. G. Epstein, H. E. Gendelman & H. A. Gelbard: Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 15, 2359-2366 (1995)
103. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman & W. Fiers: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. Embo J 12, 3095-3104 (1993)
104. Xu, Y. C., R. F. Wu, Y. Gu, Y. S. Yang, M. C. Yang, F. E. Nwariaku & L. S. Terada: Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. J Biol Chem 277, 28051-28057 (2002)
105. Wong, G. H. & D. V. Goeddel: Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941-944 (1988)
106. Prasad, N., R. S. Topping, D. Zhou & S. J. Decker: Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1 (PDK1). Biochemistry 39, 6929-6935. (2000)
107. Konishi, H., H. Matsuzaki, M. Tanaka, Y. Takemura, S. Kuroda, Y. Ono & U. Kikkawa: Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 410, 493-498. (1997)
108. Shaw, M., P. Cohen & D. R. Alessi: The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase- activated protein kinase-2. Biochem J 336, 241-246. (1998)
109. Storz, P. & A. Toker: 3′-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling. Front Biosci 7, d886-902 (2002)
110. Toker, A. & A. C. Newton: Cellular signaling: pivoting around PDK-1. Cell 103, 185-188 (2000)
111. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis & M. E. Greenberg: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96, 857-868 (1999)
112. Finkel, T.: Reactive oxygen species and signal transduction. IUBMB Life 52, 3-6 (2001)
113. Guyton, K. Z., Y. Liu, M. Gorospe, Q. Xu & N. J. Holbrook: Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271, 4138-4142 (1996)
114. Lee, Y. J., S. S. Galoforo, C. M. Berns, J. C. Chen, B. H. Davis, J. E. Sim, P. M. Corry & D. R. Spitz: Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J Biol Chem 273, 5294-5299 (1998)
115. Schiff, R., P. Reddy, M. Ahotupa, E. Coronado-Heinsohn, M. Grim, S. G. Hilsenbeck, R. Lawrence, S. Deneke, R. Herrera, G. C. Chamness, S. A. Fuqua, P. H. Brown & C. K. Osborne: Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst 92, 1926-1934 (2000)
116. Benhar, M., I. Dalyot, D. Engelberg & A. Levitzki: Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21, 6913-6926 (2001)
117. Konishi, H., M. Tanaka, Y. Takemura, H. Matsuzaki, Y. Ono, U. Kikkawa & Y. Nishizuka: Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A 94, 11233-11237 (1997)
118. Konishi, H., E. Yamauchi, H. Taniguchi, T. Yamamoto, H. Matsuzaki, Y. Takemura, K. Ohmae, U. Kikkawa & Y. Nishizuka: Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci U S A 98, 6587-6592 (2001)
119. Sevanian, A. & E. Kim: Phospholipase A2 dependent release of fatty acids from peroxidized membranes. J Free Radic Biol Med 1, 263-271 (1985)
120. Natarajan, V., M. M. Taher, B. Roehm, N. L. Pannandi, H. H. Schmid, Z. Kiss & J. G. Garcia: Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem 268, 930-937 (1993)
121. Min, D. S., E. G. Kim & J. H. Exton: Involvement of tyrosine phosphorylation and protein kinase C in the activation of phospholipase D by H2O2 in Swiss 3T3 fibroblasts. J Biol Chem 273, 29986-29994 (1998)
122. Waldron, R. T., O. Rey, E. Zhukova & E. Rozengurt: Oxidative stress induces protein kinase C-mediated activation loop phosphorylation and nuclear redistribution of protein kinase D. J Biol Chem 279, 27482-27493 (2004)
123. Wang, Y., J. M. Schattenberg, R. M. Rigoli, P. Storz & M. J. Czaja: Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated downregulation of c-Jun/AP-1. J Biol Chem 279, 31089-31097 (2004)
124. Storz, P. & A. Toker: Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. Embo J 22, 109-120 (2003)
125. Storz, P., H. Doppler, F. J. Johannes & A. Toker: Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J Biol Chem 278, 17969-17976 (2003)
126. Storz, P. & A. Toker: NF-kappaB signaling - an alternate pathway for oxidative stress responses. Cell Cycle 2, 9-10 (2003)
127. Storz, P., H. Doeppler & A. Toker: Activation Loop Phosphorylation Controls Protein Kinase D-Dependent Activation of Nuclear Factor {kappa}-B. Mol Pharmacol (2004)
128. Storz, P., H. Doppler & A. Toker: Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 24, 2614-2626 (2004)
129. Bowden, E. T., M. Barth, D. Thomas, R. I. Glazer & S. C. Mueller: An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18, 4440-4449 (1999)
130. Jaggi, M., P. S. Rao, D. J. Smith, G. P. Hemstreet & K. C. Balaji: Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun 307, 254-260 (2003)
131. Sun, X., P. Majumder, H. Shioya, F. Wu, S. Kumar, R. Weichselbaum, S. Kharbanda & D. Kufe: Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275, 17237-17240 (2000)
132. Kumar, S., A. Bharti, N. C. Mishra, D. Raina, S. Kharbanda, S. Saxena & D. Kufe: Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem 276, 17281-17285 (2001)
133. Majumder, P. K., N. C. Mishra, X. Sun, A. Bharti, S. Kharbanda, S. Saxena & D. Kufe: Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 12, 465-470 (2001)
134. Denu, J. M. & J. E. Dixon: Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr Opin Chem Biol 2, 633-641 (1998)
135. Meng, T. C., T. Fukada & N. K. Tonks: Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9, 387-399 (2002)
136. Blanchetot, C., L. G. Tertoolen & J. den Hertog: Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress. Embo J 21, 493-503 (2002)
137. Carballo, M., G. Marquez, M. Conde, J. Martin-Nieto, J. Monteseirin, J. Conde, E. Pintado & F. Sobrino: Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem 274, 93-100 (1999)
138. Wang, X., V. C. Culotta & C. B. Klee: Superoxide dismutase protects calcineurin from inactivation. Nature 383, 434-437 (1996)
139. Lee, S. R., K. S. Yang, J. Kwon, C. Lee, W. Jeong & S. G. Rhee: Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277, 20336-20342 (2002)
140. Savitsky, P. A. & T. Finkel: Redox regulation of Cdc25C. J Biol Chem 277, 20535-20540 (2002)
141. Hernandez, S. E., M. Krishnaswami, A. L. Miller & A. J. Koleske: How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 14, 36-44 (2004)
142. Shore, S. K., R. V. Tantravahi & E. P. Reddy: Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene 21, 8568-8576 (2002)
143. Skorski, T.: Oncogenic tyrosine kinases and the DNA-damage response. Nat Rev Cancer 2, 351-360 (2002)
144. Sun, X., F. Wu, R. Datta, S. Kharbanda & D. Kufe: Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 275, 7470-7473 (2000)
145. Cao, C., Y. Leng, W. Huang, X. Liu & D. Kufe: Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases. J Biol Chem 278, 39609-39614 (2003)
146. Cao, C., Y. Leng & D. Kufe: Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278, 29667-29675 (2003)
147. Frame, M. C., V. J. Fincham, N. O. Carragher & J. A. Wyke: v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol 3, 233-245 (2002)
148. Hauck, C. R., D. A. Hsia, D. Ilic & D. D. Schlaepfer: v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J Biol Chem 277, 12487-12490 (2002)
149. Li, N. & M. Karin: Is NF-kappaB the sensor of oxidative stress? Faseb J 13, 1137-1143 (1999)
150. Schreck, R., K. Albermann & P. A. Baeuerle: Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17, 221-237 (1992)
151. Hayakawa, M., H. Miyashita, I. Sakamoto, M. Kitagawa, H. Tanaka, H. Yasuda, M. Karin & K. Kikugawa: Evidence that reactive oxygen species do not mediate NF-kappaB activation. Embo J 22, 3356-3366 (2003)
152. Karin, M., Y. Cao, F. R. Greten & Z. W. Li: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2, 301-310 (2002)
153. Rayet, B. & C. Gelinas: Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938-6947 (1999)
154. Gilmore, T. D.: Malignant transformation by mutant Rel proteins. Trends Genet 1, 318-322 (1991)
155. Krappmann, D., F. Emmerich, U. Kordes, E. Scharschmidt, B. Dorken & C. Scheidereit: Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18, 943-953 (1999)
156. Darnell, J. E., Jr.: Transcription factors as targets for cancer therapy. Nat Rev Cancer 2, 740-749 (2002)
157. Hinz, M., D. Krappmann, A. Eichten, A. Heder, C. Scheidereit & M. Strauss: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19, 2690-2698 (1999)
158. Duyao, M. P., A. J. Buckler & G. E. Sonenshein: Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci U S A 87, 4727-4731 (1990)
159. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell & A. S. Baldwin, Jr.: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19, 5785-5799 (1999)
160. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green & I. M. Verma: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789 (1996)
161. Liu, Z. G., H. Hsu, D. V. Goeddel & M. Karin: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87, 565-576 (1996)
162. Beg, A. A. & D. Baltimore: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784 (1996)
163. Wang, C. Y., J. C. Cusack, Jr., R. Liu & A. S. Baldwin, Jr.: Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 5, 412-417 (1999)
164. Wang, C. Y., M. W. Mayo & A. S. Baldwin, Jr.: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787 (1996)
165. Karin, M.: How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867-6874 (1999)
166. Karin, M. & A. Lin: NF-kappaB at the crossroads of life and death. Nat Immunol 3, 221-227 (2002)
167. Wajant, H., K. Pfizenmaier & P. Scheurich: Tumor necrosis factor signaling. Cell Death Differ 10, 45-65 (2003)
168. Mercurio, F. & A. M. Manning: NF-kappaB as a primary regulator of the stress response. Oncogene 18, 6163-6171 (1999)
169. Wang, T., X. Zhang & J. J. Li: The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2, 1509-1520 (2002)
170. Janssen-Heininger, Y. M., M. E. Poynter & P. A. Baeuerle: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28, 1317-1327 (2000)
171. Takada, Y., A. Mukhopadhyay, G. C. Kundu, G. H. Mahabeleshwar, S. Singh & B. B. Aggarwal: Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278, 24233-24241 (2003)
172. Imbert, V., R. A. Rupec, A. Livolsi, H. L. Pahl, E. B. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle & J. F. Peyron: Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86, 787-798. (1996)
173. Bours, V., M. Bentires-Alj, A. C. Hellin, P. Viatour, P. Robe, S. Delhalle, V. Benoit & M. P. Merville: Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 60, 1085-1089 (2000)
174. Dhar, A., M. R. Young & N. H. Colburn: The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235, 185-193 (2002)
175. Karin, M., Z. Liu & E. Zandi: AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246 (1997)
176. Whitmarsh, A. J. & R. J. Davis: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74, 589-607 (1996)
177. Kops, G. J., T. B. Dansen, P. E. Polderman, I. Saarloos, K. W. Wirtz, P. J. Coffer, T. T. Huang, J. L. Bos, R. H. Medema & B. M. Burgering: Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress Nature 419, 316-321 (2002)
178. Karin, M.: Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 851, 139-146 (1998)
179. Sun, Y. & L. W. Oberley: Redox regulation of transcriptional activators. Free Radic Biol Med 21, 335-348 (1996)
180. Zhang, Z., X. Y. Yang & D. M. Cohen: Urea-associated oxidative stress and Gadd153/CHOP induction. Am J Physiol 276, F786-793 (1999)
181. Abate, C., L. Patel, F. J. Rauscher, 3rd & T. Curran: Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161 (1990)
182. Carballo, M., M. Conde, R. El Bekay, J. Martin-Nieto, M. J. Camacho, J. Monteseirin, J. Conde, F. J. Bedoya & F. Sobrino: Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 274, 17580-17586 (1999)
183. Li, L. & P. E. Shaw: A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun 322, 1005-1011 (2004)
184. Brunet, A., L. B. Sweeney, J. F. Sturgill, K. F. Chua. P. L. Greer, Y. Lin, H. Tran, S. E. Ross, R. Mostoslavsky, H. Y. Cohen, L. S. Hu, H. L. Cheng, M. P. Jedrychowski, S. P. Gygi, D. A. Sinclair, F. W. Alt & M. E. Greenberg: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015 (2004)
185. Tran, H., A. Brunet, J. M. Grenier, S. R. Datta, A. J. Fornace, Jr., P. S. DiStefano, L. W. Chiang & M. E. Greenberg: DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296, 530-534 (2002)
186. Hu, M. C., D. F. Lee, W. Xia, L. S. Golfman, F. Ou-Yang, J. Y. Yang, Y. Zou, S. Bao, N. Hanada, H. Saso, R. Kobayashi & M. C. Hung: IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225-237 (2004)
187. Vafa, O., M. Wade, S. Kern, M. Beeche, T. K. Pandita, G. M. Hampton & G. M. Wahl: c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9, 1031-1044 (2002)
188. Tanaka, H., I. Matsumura, S. Ezoe, Y. Satoh, T. Sakamaki, C. Albanese, T. Machii, R. G. Pestell & Y. Kanakura: E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9, 1017-1029 (2002)
189. Yokomizo, A., M. Ono, H. Nanri, Y. Makino, T. Ohga, M. Wada, T. Okamoto, J. Yodoi, M. Kuwano & K. Kohno: Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55, 4293-4296 (1995)
190. Carter, C. A. & C. J. Kane: Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem 11, 2883-2902 (2004)
191. Howitz, K. T., K. J. Bitterman, H. Y. Cohen, D. W. Lamming, S. Lavu, J. G. Wood, R. E. Zipkin, P. Chung, A. Kisielewski, L. L. Zhang, B. Scherer & D. A. Sinclair: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196 (2003)
192. Wood, J. G., B. Rogina, S. Lavu, K. Howitz, S. L. Helfand, M. Tatar & D. Sinclair: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689 (2004)
193. Stivala, L. A., M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U. M. Pagnoni, A. Albini, E. Prosperi & V. Vannini: Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276, 22586-22594 (2001)
194. Bhat, K. P. & J. M. Pezzuto: Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci 957, 210-229 (2002)
195. Bhat, K. P. L., J. W. Kosmeder, 2nd & J. M. Pezzuto: Biological effects of resveratrol. Antioxid Redox Signal 3, 1041-1064 (2001)
196. Manna, S. K., A. Mukhopadhyay & B. B. Aggarwal: Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509-6519 (2000)
197. Haworth, R. S. & M. Avkiran: Inhibition of protein kinase D by resveratrol. Biochem Pharmacol 62, 1647-1651 (2001)
198. Stewart, J. R., K. L. Christman & C. A. O'Brian: Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem Pharmacol 60, 1355-1359 (2000)
199. Storz, P., H. Doppler & A. Toker: Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB. Mol Pharmacol 66, 870-879 (2004)
200. Stewart, J. R. & C. A. O'Brian: Resveratrol Antagonizes EGFR-Dependent Erk1/2 Activation in Human Androgen-Independent Prostate Cancer Cells with Associated Isozyme-Selective PKCalpha Inhibition. Invest New Drugs 22, 107-117 (2004)
201. Subbaramaiah, K., W. J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J. M. Pezzuto & A. J. Dannenberg: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273, 21875-21882 (1998)